Detalhe da pesquisa
1.
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.
Am J Hematol;
93(7): 867-873, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29658143